Brief: InspireMD Inc Receives Reimbursement Approval For CGUARD Embolic Prevention System From The French National Authority For Health
13/10/2021 14:43
Oct 13 (Reuters) - InspireMD Inc NSPR.O :
* INSPIREMD RECEIVES REIMBURSEMENT APPROVAL FOR CGUARD™
EMBOLIC
PREVENTION SYSTEM FROM THE FRENCH NATIONAL AUTHORITY FOR HEALTH
Source text for Eikon: ID:nGNXKvXV0
Further company coverage: NSPR.O